Source: Virtual Congress 2020 – Russian speaking programme 2020: Part I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Aisanov (Moscow, Russian Federation). Pulmonary functional diagnosis of COPD. Virtual Congress 2020 – Russian speaking programme 2020: Part I

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Pulmonary rehabilitation in COPD Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Pulmonary haemodynamic in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 561s Year: 2005 Diagnosis of bronchoobstruction in patients with pulmonary tuberculosis associated chronic obstructive pulmonary disease by the forced oscillation technique Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Pulmonary embolism in COPD patients Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Pulmonary rehabilitation: COPD severity and functional outcome Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary embolism in patients with COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Pulmonary rehabilitation and exacerbations of COPD Source: Eur Respir Monogr 2021; 93: 165-181 Year: 2021 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Clinical features of COPD in patients with chronic pulmonary aspergillosis Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Pulmonary rehabilitation outcome in COPD patients Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation Year: 2003 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 Pulmonary rehabilitation in IPF Source: International Congress 2018 – Interstitial lung disease: an interdisciplinary approach Year: 2018